Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of two large Ambulatory Blood Pressure Monitoring (ABPM) studies for naproxcinod (see separate press release).

Key highlights 2007:

-- Initiation of the two remaining pivotal phase 3 trials for naproxcinod

(the 302 and 303 studies) and completion of enrollment in the 302 study

-- Presentation of the naproxcinod phase 3 results at the American College

of Rheumatology (the 301 study) and data from an Ambulatory Blood

Pressure Monitoring trial at the American Heart Association (the 104

study)

-- Initiation of a phase 2 proof-of-concept study designed to compare the

safety and efficacy of PF-03187207 to Pfizer Inc's Xalatan

-- Start of clinical development for the first nitric oxide-donating

antihypertensive by Merck & Co., Inc.

-- Initiation of a phase 2 proof-of-concept study for TPI 1020 in Chronic

Obstructive Pulmonary Disease (COPD), following promising top-line

results in a phase 2a study in asthmatic smokers

-- Establishment of NicOx' United States (U.S.) headquarters in Warren,

New Jersey, as a base for Commercial Affairs and Clinical Operations in

North America

-- Strengthening of the Company's executive management team, through the

appointment of Pascal Pfister, MD as Chief Scientific Officer (CSO),

and Sanjiv Sharma as Vice President Commercial Affairs

"We envision that 2008 will be a transformational year for NicOx. We expect to complete the pivotal phase 3 program for naproxcinod, including a pooled analysis of the Office Blood Pressure Measurements, ahead of a projected New Drug Application filing in mid-2009," said Michele Garufi, Chair
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 PuraMed BioScience ® ... of over-the-counter (OTC) medicinal and healthcare products, announced ... M name along with the name,s red and ... the trademarked name MigraPure ®  going forward. ... PuraMed,s homeopathic, natural migraine pain reliever will be ...
(Date:7/30/2014)... 30, 2014  Today the US Surgeon General issued the ... tanning or sun burns stating they can lead directly to ... Boris Lushniak , says that "skin cancer is a major ... much exposure to indoor and outdoor ultraviolet light is a ... Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... July 30, 2014  El Camino Hospital, a leader ... is utilizing the Leaf Patient Monitoring system to help ... movement of patients susceptible to bed sores. ... 138-patient study of the system, which showed dramatic improvement ... patients regularly is the one of the most effect ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3
... Conn., March 30, 2011 Attendees of the 60th ... New Orleans, La., can see first hand the benefits ... Available for sale in the U.S., Synapse 3D is ... directly into Synapse® Cardiovascular, Fujifilm,s CVIS / C-PACS. During ...
... PORT WASHINGTON, N.Y., March 30, 2011 Premier Heart, LLC ... 11, the 60th Annual Scientific Sessions and Expo of the ... in New Orleans. The MCG offers completely non-invasive cardiac testing ... diagnosis" according to its latest US FDA 510K Clearance.  MCG ...
Cached Medicine Technology:Fujifilm Highlights Synapse® 3D at ACC 2Fujifilm Highlights Synapse® 3D at ACC 3Premier Heart to Exhibit its Multifunction CardioGram (MCG™) at American College of Cardiology in New Orleans April 2-5 2
(Date:7/30/2014)... , Resistance to artemisinin, the main drug to ... among the Plasmodium falciparum ( P. ... is likely caused by a genetic mutation in ... combination therapyas opposed to a standard three-day coursehas ... according to findings published today in the ...
(Date:7/30/2014)... July 30, 2014 Volunteers from the ... counter drug abuse this summer with massive distribution of ... You can find these volunteers on Strøget, the famous ... alike for its shopping and its ambiance, some quarter ... a typical summer day. , These activities are ...
(Date:7/30/2014)... Visitors to our region recognize how special ... its protection. Bob Kiesendahl, one of the owners of ... Highlands Conservancy for donations collected through participation in the ... up fast, as visitors welcome the opportunity to invest ... , The Kiesendahl family has owned Woodloch Resort for ...
(Date:7/30/2014)... Orange, NJ. July 30, 2014. A new network of ... NIH Stroke Trials Network (NIH StrokeNet) is working ... the U.S. Despite advances of the last two ... year, stroke causes death or disability for 795,000 Americans. ... aging of the population. , To accelerate the ...
(Date:7/30/2014)... 30, 2014 LTC Consumer, an independent, free ... care insurance, features an Instant Quote tool on its website, ... of LTC Consumer. Quotes are free and unlimited. , The ... only seven areas – including age, gender, and state of ... seconds (you don’t need to enter any contact information to ...
Breaking Medicine News(10 mins):Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2
... Project (MVP) today released new data on the performance ... suggesting that the new vaccine-- expected to sell initially ... effective in protecting African children and their communities than ... ,MVP, a partnership between the World Health ...
... the notion that flu epidemics begin in areas of high ... the tropics. ,The study revealed that in ... moves later to the South region. ,This flips ... and will hopefully improve control strategies," Nature quoted Mark Miller ...
... analysis of the figures suggests that India really has between ... UN estimates of last year. The survey was carried ... lower figure for India would imply that India has managed ... States, in that the virus circulates mostly within high-risk groups. ...
... the Center for Autism and Related Disorders, will be ... highest honors -- the Wendy F. Miller National Recognition ... the organization's 38th annual national conference and exposition July ... contributions made by a psychologist, psychiatrist or other physician, ...
... spread of TB as about,420,000 of the estimated 8.8 million ... many standard anti-tuberculosis drugs, said a,WHO spokesperson. ,On ... found,to show more resistant to drugs than a similar patient ... a TB expert with WHO.,``It may reach a point we ...
... the American Journal of Clinical Nutrition, boosting key milk nutrients ... vitamin D, may do more than just help keep your ... at least 60 percent. ,The four-year clinical trial ... 55 in one of three supplement groups: 1) calcium (1400-1500mg) ...
Cached Medicine News:Health News:Improved Meningitis Vaccine for Africa Expected to End Deadly Scourge 2Health News:Improved Meningitis Vaccine for Africa Expected to End Deadly Scourge 3Health News:AIDS Incidence in India Far Lower Than Previously Estimated New Study 2Health News:AIDS Incidence in India Far Lower Than Previously Estimated New Study 3Health News:Autism Society of America Gives Top Honor to Treatment Pioneer in Phoenix 2Health News:WHO Cautions Against Spread of Drug-resistant Tuberculosis. 2Health News:Milk Nutrients may Keep Cancer at Bay. 2
... Acclaim 7000 Nd:YAG laser allows you ... cosmetic procedures such as hair removal, ... our Dermique LaserFACIAL for sun-damaged skin. ... parameters for customizing treatment based on ...
... full system for hair removal, with scanner and ... hair reduction system. The 90W laser generates ... hair bulb and bugle. To ease and optimise ... tissue through the MedArt® 413 scanner.,The laser beam ...
Reusable Components Compatible with VERSASTEP™ Reposable Access System....
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System....
Medicine Products: